Donald Notman | Chief Financial Officer |
Antony Mattessich | President & Chief Executive Officer |
Michael Goldstein | Chief Medical Officer |
Joe Catanzaro | Piper Sandler |
Dane Leone | Raymond James |
Jon Wollenben | JMP Securities |
Yi Chen | H.C. Wainwright |
Anita Dushyanth | Berenberg Capital |
Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeutix First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to introduce Donald Notman, Chief Financial Officer of Ocular Therapeutix.